MAFEIP
Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing

The MAFEIP tool has been tested by a diverse range of institutions (regional governments, large companies, SMEs, academia, etc.) for assessing the potential impact of new propositions for health and social care interventions.

The Use Cases aim to provide the results of the health and economic outcomes achieved in a variety of social and technological interventions conducted in different Actions Groups of the EIP on AHA. Examples of innovative interventions analysed with MAFEIP include novel ICT tools necessary to integrate care pathways across organisations and locations, technology scenarios for improved dementia care management, and devices for improved fall risk assessment, among others.

 

Use cases evaluated with MAFEIP

 

file
Kinesis QTUG™ is a medical device that assesses an older adults’ falls risk, frailty and mobility with the objective to facilitate the accurate and early identification of patients at risk of falling.

file
The intervention explored in this use case relates to a new approach to identifying, assessing and managing swallowing difficulties (or dysphagia).

file
A physical exercise program composed by balance and strength training was designed with the aim of reducing the prevalence of falls and its related cost.

file
The objective of Renewing Health was to implement telemedicine services in nine European regions for the validation and subsequent evaluation of these services using a patient-centred approach.

file
CareWell project has focused on the provision of care and support to older people who have complex health and social care needs. This has been achieved through ICT enabled healthcare services coordination and monitoring, patients' self‐management, and informal care givers' involvement.

file
Do CHANGE provides patients with high blood pressure, ischemic heart disease or heart failure chronic conditions with a set of tools and services to optimally monitor and manage in near real-time their health condition and disease. It has been tested in three different locations: Badalona Serveis Assitencials (BSA), the Elisabeth TweeSteden Ziekenhuis (ETZ) and the Buddhist Tzu-Chi Dalin General Hospital (BTCD).